‘‘(i) the manner in which controlled substances 
may be delivered to research sites described in sub-
paragraph (A); 
‘‘(ii) the storage and security of controlled sub-
stances at such research sites; 
‘‘(iii) the maintenance of records for such re-
search sites; and 
‘‘(iv) any other matters necessary to ensure ef-
fective controls against diversion at such research 
sites.’’. 
(d) NEW INSPECTION NOT REQUIRED IN CERTAIN 
SITUATIONS.—Subsection (f) of section 302 of the Con-
trolled Substances Act (21 U.S.C. 822) is amended— 
(1) by striking ‘‘(f) The’’ and inserting ‘‘(f)(1) 
The’’; and 
(2) by adding at the end the following: 
‘‘(2)(A) A new inspection by the Attorney General of 
a registered location is not required if a person is reg-
istered under this title to conduct research with a con-
trolled substance and applies for a registration, or for a 
modification of a registration, to conduct research with a 
second controlled substance that is— 
‘‘(i) in the same schedule as the first controlled 
substance; or 
VerDate Sep 11 2014 
20:31 Mar 09, 2022
Jkt 029200
PO 00000
Frm 00024
Fmt 6652
Sfmt 6201
E:\BILLS\H6946.IH
H6946
pamtmann on DSKBC07HB2PROD with BILLS
‘‘(ii) is in a schedule with a higher numerical 
designation than the schedule of the first controlled 
substance. 
‘‘(B) Nothing in this paragraph shall prohibit the At-
torney General from conducting any inspection if the At-
torney General deems it necessary to ensure that the reg-
istrant maintains effective controls against diversion.’’. 
(e) CONTINUATION OF RESEARCH ON SUBSTANCES 
NEWLY ADDED TO SCHEDULE I.—Section 302 of the 
Controlled Substances Act (21 U.S.C. 822) is amended 
by adding at the end the following: 
‘‘(h) CONTINUATION OF RESEARCH ON SUBSTANCES 
NEWLY ADDED TO SCHEDULE I.—If a person is con-
ducting research on a substance at the time the substance 
is added to schedule I, and such person is already reg-
istered under this title to conduct research with a con-
trolled substance in schedule I, then— 
‘‘(1) the person shall, within 90 days of the 
scheduling in schedule I, submit a completed appli-
cation for registration under this title or modifica-
tion of an existing registration under this title, to 
conduct research on such substance, in accordance 
with regulations issued by the Attorney General; 
VerDate Sep 11 2014 
20:31 Mar 09, 2022
Jkt 029200
PO 00000
Frm 00025
Fmt 6652
Sfmt 6201
E:\BILLS\H6946.IH
H6946
pamtmann on DSKBC07HB2PROD with BILLS
‘‘(2) the person may, notwithstanding sub-
sections (a) and (b), continue to conduct the re-
search on such substance until— 
‘‘(A) the person withdraws such applica-
tion; or 
‘‘(B) the Attorney General serves on the 
person an order to show cause proposing the 
denial of the application pursuant to section 
304(c); 
‘‘(3) if the Attorney General serves such an 
order to show cause and the person requests a hear-
ing, such hearing shall be held on an expedited basis 
and not later than 45 days after the request is 
made, except that the hearing may be held at a later 
time if so requested by the person; and 
‘‘(4) if the person sends a copy of the applica-
tion required by paragraph (1) to a manufacturer or 
distributor of such substance, receipt of such copy 
by such manufacturer or distributor shall constitute 
sufficient evidence that the person is authorized to 
receive such substance.’’. 
(f) TREATMENT OF CERTAIN MANUFACTURING AC-
TIVITIES AS COINCIDENT TO RESEARCH.—Section 302 of 
the Controlled Substances Act (21 U.S.C. 822), as amend-
VerDate Sep 11 2014 
20:31 Mar 09, 2022
Jkt 029200
PO 00000
Frm 00026
Fmt 6652
Sfmt 6201
E:\BILLS\H6946.IH
H6946
pamtmann on DSKBC07HB2PROD with BILLS
ed by subsection (e), is further amended by adding at the 
end the following: 
‘‘(i) TREATMENT OF CERTAIN MANUFACTURING AC-
TIVITIES AS COINCIDENT TO RESEARCH.— 
‘‘(1) IN
GENERAL.—Except as specified in 
paragraph (3), a person who is registered to perform 
research on a controlled substance may perform 
manufacturing activities with small quantities of 
that substance, including activities listed in para-
graph (2), without being required to obtain a manu-
facturing registration, if such activities are per-
formed for the purpose of the research and if the ac-
tivities and the quantities of the substance involved 
in those activities are stated in— 
‘‘(A) a notification submitted to the Attor-
ney General under section 303(l); 
‘‘(B) a protocol filed with an application 
for registration approval under section 303(f); 
or 
‘‘(C) a notification to the Attorney General 
that includes the registrant’s name and an at-
testation that the research to be conducted with 
the small quantities of manufactured substance 
is consistent with the scope of the research that 
is the basis for the registration. 
VerDate Sep 11 2014 
20:31 Mar 09, 2022
Jkt 029200
PO 00000
Frm 00027
Fmt 6652
Sfmt 6201
E:\BILLS\H6946.IH
H6946
pamtmann on DSKBC07HB2PROD with BILLS